Are melatonin doses employed clinically adequate for melatonin-induced cytoprotection?
Abstract: This review article discusses the special role that melatonin, a molecule with chronobiotic/cytoprotective properties, may have in prevention and treatment of the metabolic syndrome (MS), ischemic and non-ischemic cardiovascular diseases and Alzheimer ́...
Guardado en:
| Autor principal: | Cardinali, Daniel Pedro |
|---|---|
| Formato: | Artículo |
| Lenguaje: | Inglés |
| Publicado: |
ST BIo-Life
2019
|
| Materias: | |
| Acceso en línea: | https://repositorio.uca.edu.ar/handle/123456789/8811 |
| Aporte de: |
Ejemplares similares
-
Cytoprotection by melatonin: The metabolic syndrome as an example
por: Cardinali, Daniel Pedro, et al.
Publicado: (2022) -
Neuroendocrine-metabolic dysfunction and sleep disturbances in neurodegenerative disorders: focus on Alzheimer's disease and melatonin
por: Spinedi, Eduardo J., et al.
Publicado: (2019) -
The polycystic ovary syndrome and the metabolic syndrome : a possible chronobiotic-cytoprotective adjuvant therapy
por: Spinedi, Eduardo J., et al.
Publicado: (2019) -
Melatonin : clinical perspectives in neurodegeneration
por: Cardinali, Daniel Pedro
Publicado: (2019) -
Melatonin, mitochondria, and the metabolic syndrome
por: Cardinali, Daniel Pedro, et al.
Publicado: (2019)